摘要
宫颈癌病因明确,且存在多种筛查方案适合不同资源地区使用,尤其是预防性人类乳头瘤病毒(HPV)疫苗的成功研发,开启了宫颈癌的全面防控时代,是人类肿瘤防控史上的里程碑。但目前宫颈癌仍是全球,特别是发展中国家的重大公共健康问题,其防控瓶颈主要在于提高宫颈癌筛查和HPV疫苗的覆盖率。尤其在我国,人口众多,各地区经济发展不平衡,且HPV疫苗晚于世界十年之久,如何使更多妇女参与宫颈癌筛查、接种HPV疫苗,最终消除宫颈癌,任重而道远。
The etiology of cervical cancer has been fully demonstrated. Different screening strategies are available for different areas with various level of development. The prophylactic human papilloma virus (HPV) vaccine has launched the era of comprehensive cervical cancer control, which is the milestone in the history of human fighting against cancer. However, cervical cancer is still a major public health issue in the world, especially in developing countries. The main challenge lies in the improvement for the coverage of cervical cancer screening and HPV vaccination. Especially for China with large population, various level of the economic development, and the HPV vaccine later than the world for ten years, how to improve the coverage of cervical cancer screening and HPV vaccination? There is a long way to go for the elimination of cervical cancer.
作者
赵方辉
张莉
Zhao Fanghui;Zhang Li(Cancer Epidemiology Department,National Cancer Center/National Clinical Research Center for Cancer/ Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021, China)
出处
《中华预防医学杂志》
CAS
CSCD
北大核心
2019年第1期10-12,共3页
Chinese Journal of Preventive Medicine
基金
中国医学科学院医学与健康科技创新工程重大协同创新项目(2016-I2M-1-019).
关键词
疫苗
宫颈肿瘤
人类乳头瘤病毒
筛查
Vaccines
Uterine cervical neoplasms
Human papillomavirus
Screening